BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27518132)

  • 21. Postoperative imaging of vestibular schwannomas.
    Ginat DT; Martuza RL
    Neurosurg Focus; 2012 Sep; 33(3):E18. PubMed ID: 22937852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature.
    Vitturi BK; Grandis M; Beltramini S; Orsi A; Schenone A; Icardi G; Durando P
    J Med Case Rep; 2021 Dec; 15(1):589. PubMed ID: 34903275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late failure rate of hearing preservation after middle fossa approach for resection of vestibular schwannoma.
    Hilton CW; Haines SJ; Agrawal A; Levine SC
    Otol Neurotol; 2011 Jan; 32(1):132-5. PubMed ID: 21099729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anatomically intact but electrically unresponsive facial nerve in vestibular schwannoma surgery.
    Carlson ML; Van Abel KM; Schmitt WR; Driscoll CL; Neff BA; Link MJ
    Neurosurgery; 2012 Dec; 71(6):1125-30; discussion 1130. PubMed ID: 22986594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parsonage-Turner syndrome, affecting suprascapular nerve and especially to infraspinatus muscles after COVID-19 vaccination in a professional wrestler, a case report and literature review of causes and treatments.
    Ganjeh S; Aslani H; Kalantari KK; Roostayi MM
    BMC Neurol; 2024 Jun; 24(1):187. PubMed ID: 38840070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orbital syndrome after a surgery of vestibular schwannoma via middle fossa approach.
    Hiyama H; Kasuya H; Dan S; Hori T
    Acta Neurochir (Wien); 2003 Jan; 145(1):83-5. PubMed ID: 12545268
    [No Abstract]   [Full Text] [Related]  

  • 27. Immediate and Long-term Hearing Outcomes With the Middle Cranial Fossa Approach for Vestibular Schwannoma Resection.
    Ahmed S; Arts HA; El-Kashlan H; Basura GJ; Thompson BG; Telian SA
    Otol Neurotol; 2018 Jan; 39(1):92-98. PubMed ID: 29227454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parsonage-Turner syndrome following post-exposure prophylaxis.
    Fransz DP; Schönhuth CP; Postma TJ; van Royen BJ
    BMC Musculoskelet Disord; 2014 Aug; 15():265. PubMed ID: 25098693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parsonage-Turner Syndrome After COVID-19 Vaccination: A Case Report.
    Flikkema K; Brossy K
    JBJS Case Connect; 2021 Dec; 11(4):. PubMed ID: 34936579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of hearing preservation and facial nerve function for patients undergoing vestibular schwannoma surgery: the middle cranial fossa approach versus the retrosigmoid approach--personal experience and literature review.
    Rabelo de Freitas M; Russo A; Sequino G; Piccirillo E; Sanna M
    Audiol Neurootol; 2012; 17(2):71-81. PubMed ID: 21829012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bilateral diaphragmatic paralysis due to Parsonage-Turner syndrome].
    Tissier-Ducamp D; Martinez S; Alagha K; Charpin D; Chanez P; Palot A
    Rev Mal Respir; 2015 Sep; 32(7):742-6. PubMed ID: 25534571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery for vestibular schwannomas: a systematic review of complications by approach.
    Ansari SF; Terry C; Cohen-Gadol AA
    Neurosurg Focus; 2012 Sep; 33(3):E14. PubMed ID: 22937848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral anterior interosseous neuropathy following surgery: a case report.
    Szwejbka PE; Conter R; Tenser R; Kothari MJ
    Electromyogr Clin Neurophysiol; 2004; 44(3):183-6. PubMed ID: 15125059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical approaches for resection of vestibular schwannomas: translabyrinthine, retrosigmoid, and middle fossa approaches.
    Chamoun R; MacDonald J; Shelton C; Couldwell WT
    Neurosurg Focus; 2012 Sep; 33(3):E9. PubMed ID: 22937860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
    Arts HA; Telian SA; El-Kashlan H; Thompson BG
    Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole body magnetic resonance imaging in the diagnosis of Parsonage Turner syndrome.
    Ryan M; Twair A; Nelson E; Brennan D; Eustace S
    Acta Radiol; 2004 Aug; 45(5):534-9. PubMed ID: 15515516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Parsonage-Turner syndrome with COVID-19 infection and vaccination: a systematic review.
    Ameer MZ; Haiy AU; Bajwa MH; Abeer H; Mustafa B; Ameer F; Amjad Z; Rehman AU
    J Int Med Res; 2023 Jul; 51(7):3000605231187939. PubMed ID: 37523491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Typical brachial neuritis (Parsonage-Turner syndrome) with hourglass-like constrictions in the affected nerves.
    Pan YW; Wang S; Tian G; Li C; Tian W; Tian M
    J Hand Surg Am; 2011 Jul; 36(7):1197-203. PubMed ID: 21601996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuralgic amyotrophy: Parsonage-Turner Syndrome.
    Stutz CM
    J Hand Surg Am; 2010 Dec; 35(12):2104-6. PubMed ID: 21035964
    [No Abstract]   [Full Text] [Related]  

  • 40. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.